로딩 중…
StockDiggingStockDigging

Johnson & Johnson

JNJ· NYSE
$270.55-0.97%
2026-11-02

Financials

Valuation Metrics

Johnson & Johnson's Market Cap is $651.27B. At end of 2025 it was $503.37B. Ranked #19 of 3,118 in US market (top 0.6%), #7 of 1,644 on NYSE (top 0.4%), #2 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 0.8%) by Market Cap.

Investment Metrics(as of 2026-11-02)

MetricValue
Size
Market Cap$651.27B
Revenue$99.33B
Net Income$16.09B
Total Assets$197.43B
Net Assets$81.53B
Employees138,200
Value
P/E40.46x
P/B7.99x
P/S6.56x
EV/EBITDA22.04x
FCF Yield3.16%
Profitability
ROE19.74%
ROA8.15%
Op. Margin25.70%
Revenue Growth7.80%
Earnings Growth-35.92%
Financial Health
Debt Ratio142.15%
Total Debt$44.65B
FCF$20.59B
Cash$16.91B
Current Ratio1.02x
Net Debt/EBITDA0.90x
Dividend
Div. Yield1.95%
Div. Growth3.80%
Performance
1Y Return44.92%
1M Return5.67%
From 52W High-4.07%
1Y MDD-10.96%
Trading
Volume6,151,630 shares
Trading Value$1.66B
Per Share
EPS$6.69
BPS$33.87

Company Info

CEO Mr. Joaquin Duato
Employees 138,200
HQ New Brunswick, United States

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.